Healthcare of Ontario Pension Plan Trust Fund Grows Stock Position in Hims & Hers Health, Inc. (NYSE:HIMS)

Healthcare of Ontario Pension Plan Trust Fund grew its position in Hims & Hers Health, Inc. (NYSE:HIMS) by 164.1% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 528,142 shares of the company’s stock after buying an additional 328,142 shares during the quarter. Healthcare of Ontario Pension Plan Trust Fund’s holdings in Hims & Hers Health were worth $10,663,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in HIMS. Belpointe Asset Management LLC lifted its position in shares of Hims & Hers Health by 10.0% in the fourth quarter. Belpointe Asset Management LLC now owns 13,238 shares of the company’s stock valued at $118,000 after acquiring an additional 1,205 shares in the last quarter. Verition Fund Management LLC lifted its position in shares of Hims & Hers Health by 30.9% in the fourth quarter. Verition Fund Management LLC now owns 798,660 shares of the company’s stock valued at $7,108,000 after acquiring an additional 188,506 shares in the last quarter. Bridgefront Capital LLC lifted its position in shares of Hims & Hers Health by 176.3% in the fourth quarter. Bridgefront Capital LLC now owns 39,622 shares of the company’s stock valued at $353,000 after acquiring an additional 25,284 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of Hims & Hers Health by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 14,173,285 shares of the company’s stock valued at $126,142,000 after purchasing an additional 46,541 shares during the last quarter. Finally, B. Riley Wealth Advisors Inc. acquired a new stake in shares of Hims & Hers Health in the fourth quarter valued at approximately $155,000. Hedge funds and other institutional investors own 63.52% of the company’s stock.

Hims & Hers Health Trading Up 3.1 %

NYSE:HIMS opened at $17.66 on Friday. The firm has a market cap of $3.79 billion, a PE ratio of -1,765.50 and a beta of 1.06. The stock has a fifty day moving average price of $16.62 and a 200 day moving average price of $17.26. Hims & Hers Health, Inc. has a 12-month low of $5.65 and a 12-month high of $25.74.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, August 5th. The company reported $0.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.04 by $0.02. The firm had revenue of $315.65 million during the quarter, compared to analyst estimates of $302.43 million. Hims & Hers Health had a return on equity of 5.25% and a net margin of 1.70%. Hims & Hers Health’s revenue was up 51.8% compared to the same quarter last year. During the same period last year, the business posted ($0.03) earnings per share. Equities analysts forecast that Hims & Hers Health, Inc. will post 0.22 EPS for the current year.

Insider Activity at Hims & Hers Health

In related news, insider Michael Chi sold 9,313 shares of Hims & Hers Health stock in a transaction on Friday, July 12th. The stock was sold at an average price of $22.00, for a total value of $204,886.00. Following the completion of the transaction, the insider now directly owns 185,326 shares in the company, valued at approximately $4,077,172. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other Hims & Hers Health news, CFO Oluyemi Okupe sold 12,651 shares of Hims & Hers Health stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $16.79, for a total transaction of $212,410.29. Following the completion of the sale, the chief financial officer now directly owns 211,000 shares of the company’s stock, valued at $3,542,690. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael Chi sold 9,313 shares of Hims & Hers Health stock in a transaction dated Friday, July 12th. The stock was sold at an average price of $22.00, for a total value of $204,886.00. Following the sale, the insider now directly owns 185,326 shares of the company’s stock, valued at $4,077,172. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 524,960 shares of company stock worth $8,390,362. Company insiders own 17.71% of the company’s stock.

Wall Street Analyst Weigh In

HIMS has been the subject of several recent analyst reports. TD Cowen raised their target price on Hims & Hers Health from $15.00 to $25.00 and gave the stock a “buy” rating in a research note on Thursday, July 11th. Needham & Company LLC initiated coverage on Hims & Hers Health in a research note on Thursday, August 22nd. They set a “buy” rating and a $24.00 target price for the company. Bank of America cut their target price on Hims & Hers Health from $24.00 to $20.00 and set a “buy” rating for the company in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft raised their target price on Hims & Hers Health from $16.00 to $23.00 and gave the stock a “hold” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group raised their target price on Hims & Hers Health from $14.00 to $23.00 and gave the stock a “hold” rating in a research note on Thursday, June 27th. Eight research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $19.86.

About Hims & Hers Health

Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.